Analysis of Tumor Tissue and Circulating Genetic Material in the Blood to Obtain Further Insight in the Effectiveness of Everolimus When Combined With Exemestane
Patient Preference for Everolimus in Combination With Exemestane or Capecitabine in Combination With Bevacizumab
Everolimus in Combination With Exemestane in the Treatment of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Who Are Refractory to Letrozole or Anastrozole
|4||Active, not recruiting||
Metastatic Breast Cancer in Brazil: Characterization of Patients and Treatments
† Study has passed its completion date and status has not been verified in more than two years.